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Background. We present a rare case of bilateral moyamoya disease presenting as multiple strokes and neurological deficits, treated
with the neurosurgical procedure, encephaloduroarteriosynangiosis (EDAS), in a 2-year-old male Pakistani minor. A positive
outcome was achieved and the patient recovered fully. Case Summary. Our patient presented with a history of seizures andmultiple
episodes of hemiparesis (on and off weakness) at the age of 2 years. He had a delayed speech development and could not speak
more than a few words. He had a slight slurring of speech too. He was diagnosed with bilateral moyamoya disease on Computed
Tomography Angiography (CTA). Bilateral EDAS was done in the same year, after which his symptoms improved and patient had
moderate functional recovery. Conclusion. A rare disease, moyamoya has been left unexplored in Pakistan; physicians and surgeons
when dealingwith cases in the pediatric population presentingwith symptoms of stroke, signs of generalizedweakness, and seizures
should consider moyamoya disease as a possibility. Furthermore, this case demonstrates the effectiveness of EDAS procedure for
the treatment of moyamoya disease.
1. Background
First described in 1957, moyamoya disease, a rare cerebrovas-
cular disorder, is defined as a disease of progressive stenosis
involving the terminal portions of internal carotid arteries
as well as the anterior and middle cerebral vasculature,
associated with formation of collateral vessels at the base of
the brain [1]. The diagnosis of moyamoya is mainly based
on angiographic findings and a majority of these cases are
reported in Asia [2].
There has not been much studied regarding moyamoya
in our population as there are only two case series with a
total of 17 patients, of which 10 were of less than 12 years of
age [3, 4]. Few studies reported higher incidence of stroke in
younger age group in our part of the world as compared to
western population, which probably indicate underdiagnosis
of moyamoya [5].
Surgical treatments such as EDAS involve revasculariza-
tion of underperfused areas by creating an indirect anasto-
mosis between external and internal carotid circulation by
transposition of a segment of scalp artery onto the surface
of the brain leading to proliferation of collateral blood vessel
development [6]. The ability to develop collateral blood
vessels after EDAS procedure has shown a better result in
pediatric age group as compared to the adult population [6].
2. Case Report
We report a case of 2-year-old male patient, resident of
Punjab, Pakistan, presenting with high grade fever along with
seizures and left sided weakness of face, arm, and leg. An
MRI was recommended along with a CSF culture; the MRI
did not show any signs of stroke; it was deduced to be an
episode of a transient ischemic attack (TIA) or an infection.
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Figure 1: Preoperative CTA head showing stenosis of supraclinoid parts of bilateral ICA.
Figure 2: Postoperative CTA head showing good collateral supply to both cerebral hemispheres.
The CSF culture also was negative; the patient was treated for
meningoencephalitis and recovered in 10 days. Six months
after this initial presentation, he suffered another stroke-like
episode, this time affecting the middle cerebral artery/right
temporal artery regions with hemiparesis in the right upper
and lower extremities.
An MRI was recommended, which was positive for the
ischemic changes in the regions supplied by the abovemen-
tioned arterial regions. Blood biochemistries for Protein C
and S deficiencies were negative.
This continued when he suffered 3 more stroke-like
episodes within the following three months, which affected
his speech and vision along with right sided facial and limb
weakness. He underwent all his lab investigations such as
Hepatitis B titers, VZV titers, and poliovirus which were
negative for viral illnesses. Lupus anticoagulant was negative,
refuting presence of lupus disorders, and Hb electrophoresis
was done showing normal electrophoresis negating presence
of sickle cell disease. His coagulation profile was with normal
PT/APTT and INR values; no abnormality was seen on
echocardiogram. It is pertinent to mention that the patients’
mother had suffered tuberculosis during her pregnancy with
the patient; the TB was negative however in the patient upon
testing. He was screened for Protein C and S deficiencies,
which were negative.The patient was finally diagnosed as the
case of bilateral moyamoya disease based on CT angiogram,
which showed severe bilateral stenosis and occlusion of
supraclinoid segments of bilateral internal carotid artery
(ICA), middle cerebral artery (MCA), and proximal A1 and
bilateral Anterior Cerebral Arteries (ACAs), with an exten-
sive collateral formation and enhanced vascularity in both
cerebral hemispheres (please refer to Figure 1). Patient was
recommended for surgery andwas started onCarbamazepine
and aspirin.
He was listed for bilateral EDAS, first on the right side
of the brain to preserve the better functioning hemisphere
and four months later for the left side of the brain. He
has shown considerable improvement with no new stroke
reported after the EDAS. CT angiography was repeated after
6 months from his second surgery and showed improved
patency of collateral vessels and better anastomoses (please
refer to Figure 2). He is currently undergoing physiotherapy
and has shown continued progress in his functional recovery.
With only slight residual weakness in fine motor movements
of the right hand and some drooling and slurring of speech,
the patient is progressively getting better. He is now able to
move his limbs and can speak few words.
Patient has been seizure-free for more than a year and is
now being maintained on Carbamazepine.
3. Discussion
Moyamoya is a rare cerebrovascular disease characterized
by unilateral or bilateral progressive occlusion of internal
carotid and the proximal portion of anterior and middle
carotid arteries. The name “moyamoya” refers to “puff of
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smoke” in Japanese and defines the appearance on cerebral
angiogram of the web of collaterals formed to compensate for
the blockage [1].
The incidence of moyamoya is relatively higher in Asia
compared to Europe and North America; the disease has
also been reported from China, India, and other parts of
Asia [7].The disease predominantly affects children and often
presents with stroke or recurrent transient ischemic attacks
that are commonly accompanied by paralysis affecting one
side of the body, muscle weakness, and seizures [8]. Medical
management may involve drugs such as antiplatelet agents
which are generally given to prevent thrombosis, but the
mainstay of treatment remains surgery [9].
Revascularization procedures are preferred currently and
are aimed to reestablish blood flow to the hypoxic brain tissue
by opening occluded blood vessels [10]. Many surgical proce-
dures have been described to restore blood flow, among them
two are mostly discussed in literature; first is known as the
indirect procedure, including encephaloduroarteriosynan-
giosis (EDAS), while the second is the direct method which
includes superficial temporal artery and middle cerebral
artery (STA-MCA) bypass. Combined approaches including
both direct and indirect methods have shown good results
and are of prime significance [9].
The accepted first choice of treatment is the directmethod
which includes superficial temporal artery and middle cere-
bral artery (STA-MCA) anastomosis combined with indirect
revascularization [11]. The treatment of choice among young
children suffering frommoyamoya disease who presents with
reversible ischemic changes, transient ischemic attack, and/or
minor stroke is an indirect revascularization surgery, termed
as encephaloduroarteriosynangiosis (EDAS) [12]. There are
certain limitations related to direct revascularization pro-
cedure in the management of pediatric moyamoya disease
patients. Major reasons are tiny recipient and donor vessels
and requisite for temporary blockade of blood in the cor-
tical artery [12]. The indirect revascularization technique is
comparatively easier and results in fewer complications such
as postoperative infarctions in pediatric moyamoya disease
patients [13]. Having said that, indirect surgeries offer poorer
collateral circulation compared to direct procedures [12].
Indirect surgical methods have a higher success rate
and are used more often for pediatric moyamoya disease
patients that present with ischemic symptoms and perfusion
defects in territory of middle cerebral artery [14]. Still under
debate is the ideal treatment method for severely ischemic
pediatric moyamoya disease patients due to poor circulation
in anterior or middle cerebral arteries and those presenting
with epilepsy [15]. In a Japanese study, EDAS has proved an
efficacious procedure benefitting 75% of patients suffering
from transient ischemic attacks within one year [16]. Clinical
symptoms have been observed to improve even before angio-
graphic evidence of reperfusion.
Moyamoya being a rare disorder does not get much
clinical attention and often remains underdiagnosed as it
requires trained neurophysician and sound quality of neu-
roimaging techniques for its diagnosis. Even if diagnosed, the
treatment demands skillful expertise to perform this complex
intervention and even the slightest mishandling can worsen
the condition.
4. Conclusion
This case highlights the presence of the elusive and rare
moyamoya disease in a pediatric subset of Pakistani popu-
lation. Due to the lack of proper health resources, diagnostic
modalities, and trained health care professionals in Pakistan
along with a deficiency of dedicated stroke centers and
tertiary care centers, it is often misdiagnosed and seldom
brought to attention among neurosurgeons and physicians.
Moyamoya disease should be on the differential diagnosis for
stroke in a minor showing symptoms like focal neurological
deficits. A keen eye and timely intervention by the surgeons
and physicians may be beneficial for the patient, allowing
a proper diagnosis and subsequent management for better
outcomes.
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